- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07463456
당뇨병 발 평가를 위한 열화상 카메라 검증 (HIK-DM-2026)
당뇨병성 발 평가를 위한 열화상 카메라 검증
연구 개요
상세 설명
Each participant is assessed in a single session in a thermally stable room at 20 to 25 degrees Celsius, with relative humidity recorded as a covariate. After 15 minutes of acclimatization in a semi-Fowler position with the backrest at 30 to 45 degrees, both cameras acquire plantar thermograms from a static tripod at a fixed distance of 75 cm, with the tripod head at 90 degrees to the plantar plane and an emissivity setting of 0.98. The two radiometric acquisitions are consecutive and always less than 10 seconds apart. The order of the cameras is randomized 1:1 at participant level (sequence A: M60 then Mini2 V2; sequence B: Mini2 V2 then M60), from a list generated in advance by a team member not involved in image acquisition and kept in a password-protected file until recruitment is complete. No specific background is used.
Thermograms are exported to HIKMICRO Analyzer version 2.0.1. Six anatomical regions of interest, defined a priori and identical for both cameras, are delimited on each foot: hallux, first, third and fifth metatarsal heads, midfoot and heel. There is no post-hoc region selection and no indexing to either device. Contralateral thermal asymmetry (Delta T) is computed per region as the absolute difference in mean temperature between homologous regions of the right and left foot.
Images are renamed with an alphanumeric code that removes any explicit reference to the source device before analysis, and regions are delimited by an independent evaluator blinded to the neurological status of the participant. Technical blinding is acknowledged as partial, because the difference in spatial resolution between the two cameras may allow a trained evaluator to infer the source device.
The sample size follows the method of Walter, Eliasziw and Donner for the intraclass correlation coefficient, with a null hypothesis of ICC0 = 0.65 against an alternative of ICC1 = 0.80, alpha = 0.05, nominal power 0.80 and two observations per participant, which yields a minimum of 77 participants. The study enrolls 130 participants, which raises the actual power for this contrast to 95.7 percent and absorbs expected losses.
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Eduardo Luis Martín Javier
- 전화번호: +34 647 773 675
- 이메일: eduardo@avanza-salud.com
연구 장소
-
-
Santa Cruz de Tenerife
-
San Cristóbal de La Laguna, Santa Cruz de Tenerife, 스페인, 38201
- Clínica Avanza Salud
-
연락하다:
- Eduardo Luis Martín Javier
- 전화번호: +34 647 773 675
- 이메일: eduardo@avanza-salud.com
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
샘플링 방법
연구 인구
설명
포함 기준:
- 만 18세 이상.
- 1형 또는 2형 당뇨병 진단을 받은 자.
- 동의서를 이해하고 서명할 수 있는 능력.
제외 기준:
- 활성 발궤양.
- 하지에 대한 최근 수술.
- 연구 프로토콜을 따르지 못하게 하는 인지 장애.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Diabetes patients
Adults with diagnosed type 1 or type 2 diabetes mellitus, without active plantar ulceration, recruited from the active caseload of general podiatry and physiotherapy consultations.
|
Low-cost infrared thermographic camera (256 x 192 pixels, NETD below 40 mK) used solely as a measuring instrument.
It is not a medical device and no clinical decision is derived from its readings.
High-resolution infrared thermographic camera (640 x 480 pixels, NETD below 35 mK) used as a technical comparator.
It is not designated as a clinical or diagnostic reference standard.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Intraclass correlation coefficient for absolute agreement, ICC(A,1), between the two cameras for contralateral thermal asymmetry (Delta T) in each of six pre-specified plantar regions of interest
기간: Single measurement session (Day 1)
|
Delta T is computed per region as the absolute difference in mean temperature between homologous regions of the right and left foot.
One ICC(A,1) is reported for each of the six regions defined a priori (hallux, first, third and fifth metatarsal heads, midfoot and heel), with its 95 percent confidence interval, using the McGraw and Wong (1996) formulation, equivalent to ICC(2,1) of Shrout and Fleiss (1979), two-way random effects, single measurement.
Each region contributes 130 paired measurements.
The study hypothesis is ICC greater than or equal to 0.80, tested against a null of ICC0 = 0.65.
Neither device is treated as a reference standard.
|
Single measurement session (Day 1)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Cohen's Kappa for inter-device agreement in the binary classification of thermal asymmetry at the 2.2 degree Celsius cut-off, per region of interest
기간: Single measurement session (Day 1)
|
Overall agreement proportion and Kappa with 95 percent confidence interval for the dichotomous classification Delta T greater than or equal to 2.2 degrees Celsius versus below it, in each of the six regions.
The cut-off is used as an operational category without clinical connotation, and neither device is designated as the diagnostic reference.
|
Single measurement session (Day 1)
|
|
Consistency intraclass correlation coefficient, ICC(C,1), between the two cameras for mean plantar temperature (Tmean)
기간: Single measurement session (Day 1)
|
McGraw and Wong (1996) consistency formulation, equivalent to ICC(3,1) of Shrout and Fleiss (1979), reported with its 95 percent confidence interval.
Exploratory endpoint with a hypothesis of ICC greater than or equal to 0.75.
It is not powered by an independent sample size calculation.
|
Single measurement session (Day 1)
|
|
Bland-Altman systematic bias and 95 percent limits of agreement between the two cameras for mean plantar temperature (Tmean) and for contralateral thermal asymmetry (Delta T)
기간: Single measurement session (Day 1)
|
Systematic bias and 95 percent limits of agreement computed across the six pre-specified plantar regions of interest, for both the mean plantar temperature and the contralateral thermal asymmetry.
Neither device is treated as a reference standard.
|
Single measurement session (Day 1)
|
|
Influence of participant clinical variables on the magnitude of inter-device discordance
기간: Single measurement session (Day 1)
|
The absolute inter-device difference is analyzed against the presence of peripheral sensory neuropathy, body mass index and type of diabetes mellitus.
|
Single measurement session (Day 1)
|
|
Image acquisition time
기간: Single measurement session (Day 1)
|
Time elapsed from the end of the acclimatization period to the correct export of both thermograms, measured with a stopwatch for each participant and reported in seconds.
|
Single measurement session (Day 1)
|
|
Proportion of technically valid thermograms
기간: Single measurement session (Day 1)
|
Percentage of thermographic acquisitions that did not require repetition because of a technical error, namely defocus, participant movement or a saving failure.
|
Single measurement session (Day 1)
|
|
Participant acceptability of the measurement protocol
기간: Single measurement session (Day 1)
|
Number of participants answering yes to a single dichotomous question asked verbally at the end of the session, on whether they would consider repeating this procedure at a future appointment.
|
Single measurement session (Day 1)
|
|
Descriptive distribution of the maximum contralateral thermal asymmetry per participant
기간: Single measurement session (Day 1)
|
Median and interquartile range reported separately for each camera.
This measure is descriptive only.
It is not the primary criterion and it is not indexed to either device.
|
Single measurement session (Day 1)
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
- HIK-DM-2026-01
- CHUC_2026_24 (기타 식별자: CEIm Provincial de Santa Cruz de Tenerife, Complejo Hospitalario Universitario de Canarias)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .